Detection of anti-interferon antibodies in systemic lupus erythematosus. 1983

B E Suit, and D Axelrod, and H M Moutsopoulos, and J L Decker, and J J Hooks

In this study, we show that sera from 2 of 13 patients with clinically active systemic lupus erythematosus (SLE) contained anti-interferon alpha (anti-IFN alpha) antibody. In contrast, anti-IFN alpha activity was not detected in sera from patients with clinically inactive SLE, rheumatoid arthritis (RA), Sjögren's syndrome, or in normal individuals. None of the sera exhibited anti-IFN gamma activity. These studies show that anti-IFN antibody, like IFN itself, is most frequently observed in patients with clinically active SLE. It is also possible that the presence of IFN-anti-IFN complexes may contribute, in part, to the pathogenesis of this disease.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012859 Sjogren's Syndrome Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis. Sicca Syndrome,Sjogren Syndrome,Sjogrens Syndrome,Syndrome, Sicca,Syndrome, Sjogren's

Related Publications

B E Suit, and D Axelrod, and H M Moutsopoulos, and J L Decker, and J J Hooks
March 1979, Arthritis and rheumatism,
B E Suit, and D Axelrod, and H M Moutsopoulos, and J L Decker, and J J Hooks
May 1992, Rheumatic diseases clinics of North America,
B E Suit, and D Axelrod, and H M Moutsopoulos, and J L Decker, and J J Hooks
January 2000, Lupus,
B E Suit, and D Axelrod, and H M Moutsopoulos, and J L Decker, and J J Hooks
November 1972, Ceskoslovenska patologie,
B E Suit, and D Axelrod, and H M Moutsopoulos, and J L Decker, and J J Hooks
October 2010, Joint bone spine,
B E Suit, and D Axelrod, and H M Moutsopoulos, and J L Decker, and J J Hooks
January 2015, Lupus,
B E Suit, and D Axelrod, and H M Moutsopoulos, and J L Decker, and J J Hooks
January 1990, Polski tygodnik lekarski (Warsaw, Poland : 1960),
B E Suit, and D Axelrod, and H M Moutsopoulos, and J L Decker, and J J Hooks
January 1995, Revista clinica espanola,
B E Suit, and D Axelrod, and H M Moutsopoulos, and J L Decker, and J J Hooks
May 1972, Sovetskaia meditsina,
B E Suit, and D Axelrod, and H M Moutsopoulos, and J L Decker, and J J Hooks
December 1985, Clinics in rheumatic diseases,
Copied contents to your clipboard!